Target intelligence / Profile preview

Small nucleolar RNA U109 (snoU109)

Target
snoU109
Molecular classification
Small nucleolar RNA (snoRNA), Non-coding RNA
01

Overview

Small nucleolar RNA U109 (abbreviated snoU109, also known as LOC124901856, ENSG00000238832) is a non-coding RNA gene found on chromosome 7q22.3 in humans. It does not encode a protein but is classified as a snoRNA, a type of small, stable RNA molecule that primarily functions in the chemical modification and processing of other RNA species, most commonly ribosomal RNAs. snoRNAs act as guide RNAs, recognizing target sites on ribosomal RNA and facilitating site-specific modifications, which are essential for proper ribosome biogenesis and function. There is no current evidence linking snoU109 directly to any disease role, drug interactions, or use as a clinical biomarker[1][4][7]. This gene is a non-coding RNA, specifically a snoRNA—not a protein, enzyme, receptor, transporter, or conventional therapeutic target. Based on available gene databases and gene nomenclature, ENSG00000238832 (LOC124901856) is considered an "uncharacterized" but known small nucleolar RNA[4][7]. Because it is not a protein-coding gene and does not have an established disease association, it is not considered a standard therapeutic or diagnostic target. Supporting evidence from GeneCards and NCBI classifies LOC124901856 as an "uncharacterized" non-coding gene and specifically as a pseudogene or snoRNA, not as a protein-encoding gene[4][7]. The Angiogenes database lists ENSG00000238832 as snoU109, classified as a snoRNA gene with 22 transcripts, confirming its molecular class and gene location[1]. ENSG00000238832 encodes a small nucleolar RNA (not a protein or receptor), is not considered a therapeutic target, and is involved in ribonucleic acid modification, with no known disease or drug associations[1][4][7]. No associated protein structure or mechanism, nor established therapeutic, diagnostic, or safety data are available.

Other names
LOC124901856snoU109
02

Biological functions

RNA modification (likely 2'-O-methylation or pseudouridylation of ribosomal RNA)RNA processing

Beyond the preview

Go deeper on Small nucleolar RNA U109 (snoU109).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nucleolar RNA U109 (snoU109).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call